Bio-PrecisionAI Health

Bio-PrecisionAI Health Our unique combination of expertise in bioinformatics and AI positions us at the forefront of this rapidly evolving field.

Our goal is to design novel biologics, aptamers and small drug molecules using AI to target human diseases in the multiomics era. Our company, Bio-PrecisionAI Health LLC, is a biotech company focused on leveraging bioinformatics, computational biology, precision medicine, and artificial intelligence (AI) to revolutionize healthcare. We aim to develop innovative solutions that enable personalized a

nd targeted treatments for patients, improving outcomes and reducing healthcare costs. Our unique combination of expertise in bioinformatics, computational biology, precision medicine, and AI positions us at the forefront of this rapidly evolving field. Our goal is to design novel peptides, enzymes and proteins using AI technologies to target human diseases in the multiomics era.

04/20/2026

Gamma term (γ) in Q-Learning Explained

In Q-learning, the gamma term (γ) is the discount factor. It is a number between 0 and 1 that determines how much the agent values future rewards compared to immediate ones.

1. The Core Purpose: Time Value

Think of it like interest rates in finance: a dollar today is worth more than a dollar next year.
A reward now is certain and immediate.
A reward later is “discounted” because it takes time to reach and the future is uncertain.

2. How it works in the formula

In the Q-learning update rule, γ is multiplied by the estimated future value:

Q(s, a) ← Q(s, a) + α [ R + γ max Q(s′, a′) − Q(s, a) ]
• If γ = 0 (near-sighted):
The agent only considers the immediate reward (R). It does not plan for the future.
• If γ ≈ 1 (far-sighted):
The agent values long-term rewards almost as much as immediate ones. It may accept short-term costs to achieve better long-term outcomes.

3. Application in Biomedical Data

Choosing the right γ is critical in healthcare settings:
• Sepsis treatment (low/moderate γ):
Immediate stabilization is crucial. If γ is too high, the agent might prioritize long-term strategies the patient may not survive to benefit from.

• Cancer treatment (high γ):
Treatments like chemotherapy have short-term negative effects but long-term benefits (remission). A high γ ensures the agent stays committed to the long-term goal.

• Diabetes management (balanced γ):
The agent must balance immediate risks (e.g., hypoglycemia) with long-term complications (e.g., organ damage).

4. Mathematical Convergence

γ is also important mathematically. In tasks that can continue indefinitely, having γ < 1 ensures the total accumulated reward remains finite, allowing the algorithm to converge.

Copied

04/20/2026

Q-Learning in Reinforcement Learning

In reinforcement learning (RL), Q-learning is a foundational value-based algorithm used to find optimal decision-making strategies. In the biomedical field, it is primarily applied to develop Dynamic Treatment Regimes (DTRs)—sequences of decision rules that tailor treatments to individual patients based on their evolving health data.

Key Biomedical Applications
Precision Oncology: Q-learning models are used to optimize dosage for chemotherapy and radiotherapy. For instance, it can adjust doses to balance tumor reduction with minimizing side effects, or determine the best timing for initiating second-line therapy.

Chronic Disease Management:
Diabetes: It is used for real-time blood glucose control, specifically for optimizing insulin doses based on patient data from electronic health records (EHRs).

HIV & Kidney Disease: Algorithms help in medication selection to prevent drug resistance in HIV and control erythropoiesis-stimulating agent (ESA) administration for anemia in hemodialysis patients.

Critical Care & Sepsis: In ICUs, Q-learning aids in managing life-threatening conditions like sepsis by recommending optimal timing for antibiotics and the administration of intravenous fluids and vasopressors.

Medical Imaging:
Segmentation & Localization: Q-learning agents can determine optimal local thresholds for image segmentation or locate landmarks, such as brain tumors or lung nodules, on scans.

Image Enhancement: It is applied to optimize probe positioning in ultrasound and reduce noise or artifacts in clinical data.

Drug Discovery: Applications include drug sensitivity screening and ranking prediction algorithms for specific drug-cell line pairs.

Advanced Variants in Biomedical Data

Standard Q-learning uses a Q-table to store values for state-action pairs, which becomes unmanageable with complex biomedical data. To handle high-dimensional data, researchers use:

Deep Q-Networks (DQN): Replaces tables with neural networks to handle complex features like patient vital signs, laboratory values, and medical history.

Fitted Q-Iteration (FQI): Often used for optimizing mechanical ventilation and sedation weaning time in clinical data.

Deep Spectral Q-learning: Integrates Principal Component Analysis (PCA) to handle mixed-frequency data common in mobile health applications.

Copied

Yesterday, I attended the 19th Annual Business of Biotech conference at Moffitt Cancer Center in Tampa, Florida—one of T...
04/11/2026

Yesterday, I attended the 19th Annual Business of Biotech conference at Moffitt Cancer Center in Tampa, Florida—one of Tampa Bay’s premier gatherings for biotech innovation.

The event brought together 450+ biotech executives, entrepreneurs, venture capitalists, angel investors, and researchers to discuss the latest advances in cancer care.

Sitting in a room with billionaire venture capitalists, angel investors, and biotech leaders from some of the world’s best biotech companies was a reminder that this is the kind of learning experience founders, entrepreneurs and innovators cannot afford to bypass while building.

One of the highlights was touring Moffitt Cancer Center, where precision medicine is actively practiced.

We saw firsthand how a patient journey is deeply integrated across disciplines:
From basic science to translational medicine, patients undergo comprehensive testing—including whole genome sequencing, RNA-Seq analysis powered by bioinformatics, and pharmacokinetic evaluation to guide highly personalized treatment decisions.

It was exciting to see technologies like Illumina sequencing platforms and nanopore sequencing in action, with demonstrations of how these sequencers generate and process genomic data.

Moments like this reinforce the future we’re building toward—where AI, genomics, and medicine converge to deliver truly personalized healthcare.

Grateful for the opportunity to learn, connect, and be inspired to build!

Photo with my Bio-PrecisionAI Health Colleague, Nucleate Florida Colleague and our members!

~ Joseph Luper Tsenum

From Established Machine Learning to Intuition → to Generative AI in Drug DiscoveryIn 2024, my company, Bio-PrecisionAI ...
04/09/2026

From Established Machine Learning to Intuition → to Generative AI in Drug Discovery

In 2024, my company, Bio-PrecisionAI Health, was selected among NIH-backed companies to pitch at the BIO International Convention in San Diego.

During the convention, I attended several sessions on AI in drug discovery and healthcare. One panel that stood out featured Alex Zhavoronkov, Founder and CEO of Insilico Medicine, whose perspective differed meaningfully from others.

Here are a few key takeaways that continue to shape how we build and think about drug discovery at Bio-PrecisionAI Health:

1. 🧠 Intuition Still Matters

Even in AI-driven drug discovery, experienced medicinal chemists and domain experts remain essential. Their intuition built from years of experience helps identify promising candidates that models alone may miss.

👉 The future is not AI replacing experts, but AI + domain expertise working together.
Cross-functional collaboration (chemistry, AI, biology, robotics) is critical.

2. 🔬 Proven Machine Learning Methods Still Win

While generative AI is exciting, established ML methods (QSAR, Random Forests, etc.) have already contributed to real drug discovery outcomes.

👉 For early-stage companies, these methods:
• Provide reliability
• Scale efficiently
• Support regulatory credibility

Don’t ignore what already works.

3. 🤖 Embrace Generative AI — Globally

Generative AI is reshaping drug discovery, but innovation is happening worldwide.

👉 It’s important to:
• Track global competitors
• Learn from advances outside the U.S. (especially rapidly advancing ecosystems like Chinese companies)
• Continuously adapt your approach

4. 📢 Publish and Share Progress

Publishing results builds:
• Scientific credibility
• Trust with partners
• Visibility in the ecosystem

Transparency (when strategic) accelerates growth.

5. 💊 Design for Licensing and Partnerships

Validated drug candidates should be:
• Positioned for licensing
• Structured for collaboration

👉 This is how early-stage biotech scales.

6. 🧬 Diversify Your Pipeline

Relying on a single target or program is risky.

👉 Strong companies:
• Expand across multiple targets
• Build a portfolio of opportunities
• De-risk their pipeline early

🔥 Final Thought

The future of drug discovery isn’t just generative AI, it’s the integration of intuition, proven ML, and next-generation models into a cohesive system.

Learn more from our website: https://bioprecisionai.com

Joseph Luper Tsenum
~ From Bio-PrecisionAI Health

Post edited by ChatGPT

Bio-PrecisionAI Health is an AI-driven biotech company advancing drug discovery, biomarker discovery, and computational research strategy.

Our AI in Biotech event yesterday at UF Innovate Accelerate, Florida. It was such a great learning experience from Biote...
04/03/2026

Our AI in Biotech event yesterday at UF Innovate Accelerate, Florida. It was such a great learning experience from Biotech companies and the academia. More photos and videos on the way. Many thanks to Dylan Tan, our CTO for pitching our progress report to inspire students, the industry and academia.

Coming up tomorrow being ThursdayRegister and attend if you’re in Florida, this is an in-person event. 🎟️ Limited seats ...
04/02/2026

Coming up tomorrow being Thursday

Register and attend if you’re in Florida, this is an in-person event.

🎟️ Limited seats — secure yours now: https://luma.com/mk64kffy

Share with colleagues living around Florida and its environs!

Bio-PrecisionAI Health is excited to launch its website today: http://bioprecisionai.comLearn more about what we’re buil...
04/01/2026

Bio-PrecisionAI Health is excited to launch its website today: http://bioprecisionai.com

Learn more about what we’re building!

Bio-PrecisionAI Health is an AI-driven biotech company advancing drug discovery, biomarker discovery, and computational research strategy.

03/30/2026

Even as a Silicon Valley reporter, you don’t meet a founder every day who has the potential to change the world. Eve Bodnia is one of them. With her startup Logical Intelligence, the 33-year-old physicist is challenging the entire approach of the industry.

💥 In the AI boom, a simple logic has prevailed so far: more data, more chips, more computing power. Companies like OpenAI, Anthropic, and Google are relying on ever-larger models to continuously increase the performance of their systems. The result: ever-higher energy consumption—and persistent problems with the reliability of the models.

💥 Bodnia’s company relies on a different type of model than the large language models ( ) on which systems like ChatGPT or Claude are based. So-called “Energy-Based Models” ( ) are designed to solve tasks not only more precisely but also with significantly less energy consumption. They are intended to compute as efficiently as possible, think logically, and not hallucinate.

💥 In a demonstration a few weeks ago, the company showed something astonishing: their first model was able to solve the number puzzle many times faster than conventional AI models. According to Logical Intelligence, the solution cost 4 dollars in computing power, while the competition’s cost a full 11,000 dollars.

💥 The new approach enables “a new generation of more reliable AI systems,” Yann LeCun told us. The Turing Award winner and perhaps the most influential critical voice in the AI world is now assisting Bodnia as chairman of the technical research board.

Link to the full Handelsblatt story with Lina Sophie Knees, numbers and crucial insights by Kristian Kersting and Patrick Hillmann in the comments.

Copied

03/28/2026

Mark your calendars! Raia AI is hosting a half-day event on April 28th you won’t want to miss. 🚨

Discover how this platform helps organizations automate complex tasks across support, development, and operations. This session is perfect for leaders, founders, faculty, and community innovators ready to explore AI's real-world impact.

🔗 Secure your spot here: https://raialiveatufinnovate.raia.run/ #/

03/28/2026
🚨 Call for Instructors & Teaching Assistants! 🚨  Are you ready to mentor the next generation of tech leaders? The 3rd NE...
03/27/2026

🚨 Call for Instructors & Teaching Assistants! 🚨

Are you ready to mentor the next generation of tech leaders?

The 3rd NELIREF Data Science & AI Summer School is officially seeking passionate experts to join our teaching team for 2026!

We are looking for hands-on Instructors and TAs proficient in English to lead sessions in:

- Python Programming
- Machine Learning (Supervised & Unsupervised)
- Git & GitHub
- AI Assistants & Vibe Coding
- Deep Learning
- NLP, LLMs & Generative AI

Program Schedule:
🗓 Dates: June 19–20 & 26–27, 2026
⏰ Daily Sessions:
• Session 1: 8:00 AM – 12:30 PM WAT (3:00 AM – 8:30 AM EDT)
• Session 2: 2:00 PM – 5:00 PM WAT (9:00 AM – 12:00 PM EDT)

How to Join Us:
If you have practical experience and a drive to teach, we want to hear from you!
📌 Apply Here: bit.ly/4uHr9dv
⚠️ Deadline: May 20th, 2026

Note: Shortlisted candidates will be invited for an interview.

Help us bridge the gap in AI education and empower students from all backgrounds! 💡

📌 Apply Here: bit.ly/4uHr9dv
03/27/2026

📌 Apply Here: bit.ly/4uHr9dv

Address

Techwood Drive NW
Atlanta, GA
30313

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Bio-PrecisionAI Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Bio-PrecisionAI Health:

Share